Blood marker to predict ICU patient outcomes
Part of Mental health clinical trials.
This study measures a specific blood protein (carbohydrate-deficient transferrin) when patients arrive at the hospital to see if it can predict how well they'll do in the intensive care unit. Understanding this marker might help doctors better plan care for critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were admitted to the Emergency Department and then transferred to the ICU at this hospital
- You do not have liver cirrhosis (scarring of the liver)
- You are not pregnant
- You have a working IV line (needle in your vein) for blood draws
- You stay in the ICU at this hospital—you are not transferred to another hospital before your ICU stay ends
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether certain blood tests can help predict the risk of death after surgery in ICU patients. If you have had surgery and are now in the ICU, your blood samples may help doctors learn more.
This study uses artificial intelligence to better predict which ICU patients might need a blood transfusion. The goal is to make transfusion decisions more precise and personalized, potentially reducing unnecessary transfusions and improving care.
This study looks at how a simple blood test called prealbumin—a protein that reflects your nutrition and overall health—changes over time in critically ill patients. By tracking these changes, doctors hope to better predict recovery and outcomes, which could help guide treatment decisions.
This study looks at whether a simple blood test ratio can help predict how well critically ill patients do in the intensive care unit (ICU). It aims to understand if stress-related high blood sugar affects recovery.
This study looks at two blood test numbers (HbA1c, which shows average blood sugar over time, and RDW, which shows red blood cell size) to see if they can help predict how well critically ill patients will do. If you have diabetes or anemia and are in intensive care, this study might help understand your condition better.
This study looks at a blood marker called nucleosomes to see if it can help predict how critically ill patients will do. By measuring this marker, doctors hope to better understand and support patients like you in the ICU.
Hear when a new Intensive Care (ICU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.